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Abstract 12-Hydroxyeicosatetraenoic acid (12-HETE), a pro-
duct of the platelet lipoxygenase pathway, amplifies tissue factor
expression by P-selectin-stimulated monocytes in a time- and
dose-dependent fashion. The same effect is observed when
monocytes are incubated with Chinese hamster ovary cells
transfected with the P-selectin cDNA. Both 5-HETE and
leukotriene C4 are inactive in this system. Furthermore, the
effect is not dependent on non-specific monocyte adhesion, since
monocytes incubated with CHO cells expressing E-selectin do
not express tissue factor, either in the presence or in the absence
of 12-HETE. These results show that 12-HETE is a cofactor for
the expression of tissue factor by monocytes.
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1. Introduction
Tissue factor is constitutively expressed on non-vascular
cells, and is therefore immediately available for binding to
factor VIIa following vascular damage and activation of
blood coagulation [1]. However, when appropriately stimu-
lated, endothelial cells and monocytes can also synthesize tis-
sue factor and express it on their surface. Numerous agonists
have been shown to activate tissue factor synthesis by mono-
cytes, including bacterial endotoxin [2,3], immune complexes
[4], cytokines [5], malignant cells [6] and platelets [7].
The molecular basis for platelet-mediated stimulation of
tissue factor by monocytes has been examined. P-selectin is
a member of the selectin family of cell-cell adhesion molecules
synthesized by platelets and endothelial cells. In resting cells,
P-selectin is an integral component of the alpha-granule and
the Weibel-Palade body membrane [8^10]. Upon cell stimula-
tion and degranulation, P-selectin is translocated to the plas-
ma membrane [8,11], where it functions as an adhesion recep-
tor for neutrophils and monocytes [12,13] that constitutively
express the mucin-like glycoprotein P-selectin glycoprotein
ligand-1 (PSGL-1) [14]. More recently, P-selectin-mediated
binding of Th2 lymphocytes to stimulated endothelial cells
has also been reported [15]. We have demonstrated that in
addition to mediating cell-cell adhesion, P-selectin mediates
intracellular signaling events that lead to the synthesis of tis-
sue factor by monocytes [16]. However, P-selectin is a rela-
tively weak agonist when compared to intact platelets, sug-
gesting that other platelet-derived molecules might be
involved in monocyte stimulation.
12-Hydroxyeicosatetraenoic acid (12-HETE) is an arachi-
donic acid metabolite produced by platelets upon the action
of the enzyme 12-lipoxygenase [17]. 12-HETE mediates nu-
merous biologic functions, including enhancement of surface
expression of integrins and of cell-cell adhesion, induction of
endothelial cell retraction, and increase in metastases of tumor
cells [18]. We have previously shown that 12-HETE also up-
regulates tissue factor synthesis by endotoxin-stimulated
monocytes, while it has no e¡ect in resting monocytes [19].
We therefore reasoned that 12-HETE could function as a co-
stimulus in upregulating tissue factor by P-selectin-stimulated
monocytes. In the present study, we demonstrate that 12-
HETE enhances the expression of tissue factor on mononu-
clear cells exposed to P-selectin.
2. Materials and methods
2.1. Chemicals and cell lines
RPMI 1640 medium, Alpha medium, L-glutamine, penicillin, strep-
tomycin and fetal bovine serum (FBS) were obtained from Biochrom
(Berlin, Germany). Dialyzed fetal bovine serum was from Gibco BRL
(Grand Island, NY, USA). Sodium citrate solution 3.8%, N-2-hydroxy-
ethylpiperazine-NP-2-ethanesulfonic acid (HEPES) and sodium car-
bonate were obtained from Merck (Darmstadt, Germany). Adenosine,
deoxyadenosine and thymidine were purchased from Sigma Chemical
Co. (St. Louis, MO, USA). Methotrexate was obtained from Lederle
Laboratories Division (Wayne, NJ, USA). Lymphoprep was from
Nycomed Pharma AS (Oslo, Norway). Chromogenic Limulus Ame-
bocyte assay was purchased from BioWhittaker Bioproducts (Wal-
kersville, MD, USA). Sterile pyrogen-free microtubes were obtained
from Sarstedt (Numbrecht, Germany). Tissue culture plates were ob-
tained from Falcon Labware Division, Becton Dickinson Co. (Ox-
nard, CA, USA). P-selectin was puri¢ed from platelets as described
[12]. 12-(S)-Hydroxyeicosatetraenoic acid (12-HETE), 5-(S)-hydroxy-
eicosatetraenoic acid (5-HETE) and leukotriene C4 (LTC4), purchased
from Biomol Research Labs (Philadelphia, PA, USA) were dissolved
in alcohol, dried, then dissolved in 0.01 M Na2CO3 (10 Wg/16.5 Wl
Na2CO3). Further dilutions were carried out in RPMI 1640 medium.
All the steps were carried out in a nitrogen atmosphere in order to
prevent oxidation. Chinese hamster ovary (CHO) cells expressing
P-selectin (CHO:P-selectin) or E-selectin (CHO:E-selectin) adhere to
leukocytes, in contrast to CHO cells [12].
2.2. Cell isolation and culture
Blood was obtained from healthy volunteers and anticoagulated
with 0.1 vol of a 3.8% sodium citrate solution. Leukocytes were sedi-
mented at 200Ug for 15 min at 10‡C. Platelet-rich plasma was dis-
carded, and the sedimented cells were adjusted to the original volume
with 0.38% sodium citrate solution/0.15 M NaCl. After centrifugation
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and removal of the platelet-rich supernatant, the sedimented cells were
collected and diluted to twice the original volume with citrate-saline,
layered onto Lymphoprep and sedimented at 740Ug for 20 min at
20‡C. Mononuclear cells were collected, diluted in citrate-saline and
sedimented at 680Ug for 7 min at 8‡C. Mononuclear cells were
washed three times by resuspension in citrate-saline and sedimented
at 250Ug for 15 min at 8‡C. Mononuclear cells were then resus-
pended in RPMI 1640 medium supplemented with penicillin (100 U/
ml) and streptomycin (100 Wg/ml) at a cell concentration of 107 cells/
ml.
Cell viability exceeded 96% as measured by the trypan blue exclu-
sion test. The monocytes were 25^30% in this cell population, as
assessed by non-speci¢c esterase staining. Mononuclear cells were in-
cubated with puri¢ed P-selectin or CHO cells in sterile, pyrogen-free
stoppered test tubes or in tissue culture plates at 37‡C under 5% CO2/
95% air.
CHO, CHO:P-selectin, and CHO:E-selectin cells were cultured in
24 well tissue culture plate under 5% CO2/95% air with Alpha medium
supplemented with HEPES (10 mM), L-glutamine (2 mM), penicillin
(100 U/ml), streptomycin (100 Wg/ml). CHO cell culture medium re-
quired, in addition, heat-inactivated FBS (10%) and a mixture of
adenosine, deoxyadenosine, and thymidine (0.01%). Dialyzed, heat-
inactivated FBS (10%) and methotrexate (200 nM) were required
for CHO:P-selectin and CHO:E-selectin growth. Con£uent cells
were washed three times with RPMI 1640 before mononuclear cell
coincubation.
2.3. Control of endotoxin contamination
Sterile, pyrogen-free working conditions were observed in order to
avoid any contamination by endotoxin. Solutions were prepared in
glassware rendered pyrogen-free by heating at 180‡C for 3 h. Reagents
were dissolved in sterile pyrogen-free solvents, and, when tested for
endotoxin contamination by the Limulus assay, were found negative
at a sensitivity threshold of 0.1 endotoxin unit/ml, corresponding to
0.01 ng/ml.
2.4. Tissue factor assay
After incubation, cells were disrupted by three freeze-thaw cycles
before testing for procoagulant activity by a one stage clotting time
test as previously described [20]. Disrupted cells (100 Wl) were mixed
with 100 Wl of normal human plasma at 37‡C. After 30 s, 100 Wl of 25
mM CaCl2 at 37‡C was added to the mixture and the time to clot
formation was recorded. Results were expressed in arbitrary units (U)
by comparison with a standard curve obtained using a human brain
thromboplastin standard kindly donated by Dr. L. Poller, Manches-
ter, UK. This preparation was assigned a value of 1000 U for a
clotting time of 20 s. The standard curve was linear from 1000 to
0.01 U, corresponding to clotting times of 20 and 511 s, respectively.
We have previously demonstrated that this coagulant activity repre-
sents the biological activity of tissue factor since the expression of
coagulant activity on monocytes is blocked by antibodies to tissue
factor, and correlates with the development of tissue factor mRNA
and tissue factor antigen [16].
3. Results
Puri¢ed P-selectin stimulates procoagulant activity expres-
sion in mononuclear cells (Fig. 1) as previously shown [16].
The e¡ect was inhibited by the monoclonal anti-P-selectin
antibody, GA6. Heat denaturation of P-selectin abolished up-
regulation of the activity, indicating that endotoxin contami-
nation was not responsible for tissue factor expression. Iden-
tity of the procoagulant activity elicited under these
conditions with tissue factor was con¢rmed by inhibition
with a speci¢c monoclonal anti-tissue factor antibody [16].
When 12-HETE was added together with puri¢ed P-selec-
tin, tissue factor expression was increased by 4^5-fold (Fig. 1).
No e¡ect could be observed when 12-HETE was incubated
with mononuclear cells alone. The lack of e¡ect of 12-HETE
in the absence of other stimuli con¢rms previous results [19],
and indicates that no endotoxin was contaminating the 12-
HETE preparation since 12-HETE is capable of upregulating
tissue factor synthesis in the presence of even small amounts
of endotoxin [19].
In order to mimic physiologic conditions in which P-selectin
is expressed within a cell membrane, as it is in activated pla-
telets and endothelial cells, we used CHO:P-selectin cells. As
shown in Fig. 2, in the absence of 12-HETE, CHO:P-selectin
induced tissue factor activity in mononuclear cells, as previ-
ously shown [16]. 12-HETE, at concentrations up to 5 WM,
potentiates the e¡ect of P-selectin expressed by CHO:P-selec-
tin cells. Higher concentrations of 12-HETE do not increase
this e¡ect. No increase in activity was observed when 12-
HETE was added to mononuclear cells cultured in the pres-
ence of untransfected CHO. The viability of mononuclear
cells incubated with these reagents, as assessed by trypan
blue dye exclusion, was not a¡ected (not shown).
The kinetics of 12-HETE enhancement of tissue factor ex-
pression by P-selectin-stimulated mononuclear cells is shown
in Fig. 3. CHO:P-selectin-induced tissue factor expression
peaked at 6 h. The time course of tissue factor expression
resulting from addition of 12-HETE parallels that of
CHO:P-selectin alone.
In addition to 12-HETE, we examined the e¡ects on tissue
factor expression of 5-lipoxygenase products that can be
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Fig. 1. E¡ect of P-selectin and 12-HETE on tissue factor expression
in mononuclear cells. Tissue factor (TF) expression was measured in
mononuclear cells (MN) that were untreated or exposed to P-selec-
tin (250 ng/ml), 12-HETE (20 WM), or P-selectin and 12-HETE for
20 h at 37‡C. At the end of incubation samples were frozen and
thawed, and tissue factor activity was measured as described in Sec-
tion 2.
Fig. 2. 12-HETE enhances expression of tissue factor in mononu-
clear cells cultured with CHO:P-selectin cells. Mononuclear cells
were added and incubated with con£uent CHO and CHO:P-selectin
for 6 h in the presence of di¡erent concentrations of 12-HETE. At
the end of incubation, cells were treated as for Fig. 1.
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formed by leukocytes, such as 5-HETE and LTC4. When
tested under identical conditions no e¡ect on tissue factor
activity could be observed (Fig. 4).
We have previously shown that monocyte stimulation in-
duced by CHO:P-selectin was indeed due to P-selectin: E-
selectin bearing CHO cells do not stimulate tissue factor ex-
pression in monocytes [16]. The data depicted in Fig. 5 con-
¢rm these results. Tissue factor expression was induced in
mononuclear cells by CHO:P-selectin, and not by CHO:E-
selectin cells. The presence of 12-HETE, responsible for an
increase in tissue factor activity when incubated with
CHO:P-selectin, had no e¡ect on monocytes when added to
CHO:E-selectin cells.
4. Discussion
Among the cells in contact with blood, monocytes and vas-
cular endothelial cells, which do not constitutively express
tissue factor activity under resting conditions, synthesize and
express tissue factor on their membranes in response to acti-
vating agents [2^5]. In this way, activated monocytes and
endothelial cells have the potential to promote the local gen-
eration of thrombin and the local deposition of ¢brin. During
activation, platelets translocate P-selectin from the alpha-
granules to the external membrane [8,11]. P-selectin is an ad-
hesion molecule which mediates binding of monocytes and
neutrophils to activated platelets and endothelial cells
[12,13]. It has been shown in an ex vivo model of thrombosis
that P-selectin mediates leukocyte-platelet binding within
thrombi, and that anti-P-selectin antibodies inhibit ¢brin dep-
osition after leukocyte accumulation on a vascular graft [21].
Moreover, we have shown that P-selectin upregulates tissue
factor in monocytes [16]. This phenomenon is dependent upon
binding of P-selectin to the ligand PSGL-1 since antibodies to
PSGL-1 block the P-selectin e¡ect [22]. Recently, monocyte
tissue factor expression induced by platelet-monocyte binding
was con¢rmed to be P-selectin dependent [23]. Since the stim-
ulatory e¡ect of P-selectin on monocyte tissue factor expres-
sion is relatively weak compared to that of platelets [16], it is
possible that other molecules released at the sites of vascular
injury might enhance the stimulation.
In this report, we have demonstrated that 12-HETE ampli-
¢es tissue factor expression in P-selectin-stimulated mononu-
clear cells. The ampli¢cation occurs both with puri¢ed P-se-
lectin and with CHO cells transfected with P-selectin. The
e¡ect of 12-HETE is speci¢c, since 5-HETE and LTC4 were
inactive in our test system, in contrast to the chemotactic,
chemokinetic and spasmogenic activities that leukotrienes ex-
ert [24].
12-HETE is the end product of the 12-lipoxygenase-medi-
ated pathway of arachidonic acid metabolism [17]. In addition
to its known chemotactic activities [25], 12-HETE has been
shown to mediate several other biological functions. Evidence
suggests that exogenous 12-HETE can increase surface expres-
sion of integrins, enhance cell-cell adhesion, induce endothe-
lial cell retraction, and increase metastasis of tumor cells [26].
Moreover, we have shown that 12-HETE upregulates tissue
factor synthesis by monocytes stimulated by endotoxin [19].
Although 12-HETE was originally reported to derive exclu-
sively from platelets, recently the presence of a 12-lipoxygen-
ase has also been reported in human aortic endothelial cells
[27] and mononuclear cells [27,28].
The requirement for a second agonist for full expression of
P-selectin-mediated signaling has been described in several
recent studies which have focused on the role of selectins in
monocyte activation and signal transduction. Binding of P-
selectin regulates expression and secretion of the in£ammatory
cytokines monocyte chemotactic protein-1 (MCP-1) and tu-
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Fig. 5. E¡ect of 12-HETE on tissue factor activity of mononuclear
cells incubated with CHO:P-selectin or CHO:E-selectin. Mononu-
clear cells were incubated with CHO:P-selectin or CHO:E-selectin
with or without 12-HETE (5 WM) for 6 h, and then assayed for tis-
sue factor activity. Results are expressed in percent of tissue factor
activity. A 100% value was assigned to the activity expressed by
mononuclear cells incubated with CHO:P-selectin.
Fig. 4. E¡ect of 12-HETE, 5-HETE, and LTC4 on tissue factor of
P-selectin-stimulated mononuclear cells. Mononuclear cells (MN)
were incubated with CHO:P-selectin in the presence of 12-HETE,
5-HETE, or LTC4 (5 WM each) for 6 h. At the end of incubation,
the cells were tested for tissue factor activity. Results are expressed
in percent of tissue factor activity. A 100% value was assigned to
the activity expressed by mononuclear cells incubated with CHO:P-
selectin in the absence of the di¡erent agents.
Fig. 3. Kinetics describing the development of tissue factor expres-
sion in mononuclear cells exposed to 12-HETE and CHO or
CHO:P-selectin. Mononuclear cells were incubated with CHO or
CHO:P-selectin in the presence of 12-HETE (5 WM). After the indi-
cated times, the cells were assayed for tissue factor activity.
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mor necrosis factor-K by monocytes stimulated by platelet
activating factor (PAF) [29]. In their experimental system,
P-selectin alone was not su⁄cient to elicit these responses.
P-selectin was able to cause a small but discernible transloca-
tion of NF-UB, a transcription factor involved in the activa-
tion of several immediate early genes. This phenomenon is
greatly enhanced by PAF, which is required for full stimula-
tory function at the protein level [29]. Similarly, a priming
e¡ect of P-selectin was proposed for the synthesis of PAF
by monocytes exposed to opsonized zymosan [30]. Finally, it
has recently been reported that platelet-induced upregulation
of synthesis and expression of MCP-1 and interleukin-1L by
monocytes, although dependent upon P-selectin mediated cell-
cell binding, requires the presence of the platelet chemokine
RANTES [31]. These authors could not detect tissue factor
activity when platelets were incubated with monocytes. This
result is in disagreement with other reports [7,16,19,23,32],
and may relate to their use of either thrombin-activated pla-
telets or di¡erent experimental conditions.
In summary, activated platelets co-localize with monocytes
at sites of vascular injury and in£ammation. P-selectin on
activated platelets and the damaged endothelial cells is most
likely responsible for monocyte accumulation. 12-HETE, re-
leased from activated platelets, and possibly from endothelial
cells or bound monocytes, enhances expression of tissue factor
which is required for thrombogenesis and wound healing.
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